|  | 30-day mortality | Long-term mortality |  | |
---|---|---|---|---|---|
Baseline parameters | SD | Adjusted HR (95Â % CI) | P value | Adjusted HR (95Â % CI) | P value |
Alkaline phosphatase, U/L | 68.9 | 1.36 (1.10–1.68) | 0.004 | 1.27 (1.03–1.56) | 0.023 |
Bilirubin total, mg/dl | 2.0 | 1.22 (1.07–1.40) | 0.004 | 1.22 (1.07–1.39) | 0.003 |
Aspartate transaminase, U/L | 303.5 | 1.07 (0.90–1.27) | 0.44 | 1.05 (0.91–1.22) | 0.48 |
Alanine transaminase, U/L | 192.0 | 1.11 (0.93–1.33) | 0.27 | 1.08 (0.93–1.26) | 0.30 |
AST/ALT ratio, n | 1.9 | 0.90 (0.70–1.17) | 0.43 | 0.89 (0.74–1.08) | 0.24 |
γ-Glutamyl transferase, U/L | 133.3 | 1.09 (0.87–1.35) | 0.47 | 1.12 (0.95–1.31) | 0.18 |
Albumin, g/L | 8.7 | 0.81 (0.65–1.01) | 0.06 | 0.83 (0.71–0.98) | 0.028 |
Normotest, % | 30.0 | 1.03 (0.81–1.31) | 0.81 | 1.06 (0.88–1.26) | 0.56 |